The 4th International Symposium of the Japanese Society of Gastroenterology-International Session of the 34th Annual Meeting- Announcement Pages: N2 - N2
The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations R. ShimoyamaS. SekiguchiA. Yachi Serology and Epidemiology Pages: 1 - 5
The clinical significance of reactivity to individual epitopes of the hepatitis C viral genome Hiroshi YatsuhashiKaoru InokuchiMichitami Yano Serology and Epidemiology Pages: 6 - 11
Detection of HCV RNA using reverse transcription and nested polymerase chain reaction in chronic non-A, non-B liver diseases in Korea Young Min ParkSeung Kew YoonBoo Sung Kim Serology and Epidemiology Pages: 12 - 16
Prevalence of hepatitis C virus related to liver diseases in Korea Boo Sung KimYoung Min Park Serology and Epidemiology Pages: 17 - 22
The role of hepatitis C virus in chronic hepatitis B virus infection Wan-Long ChuangWen-Yu ChangChien-Jen Chen Serology and Epidemiology Pages: 23 - 27
Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan Mobin KhanMusharraf HusainKendo Kiyosawa Serology and Epidemiology Pages: 28 - 31
Epidemiology of hepatitis C virus infection in Australia Geoffrey C. FarrellMartin WeltmanRita Lin Serology and Epidemiology Pages: 32 - 36
Historical patterns of prolonged hepatitis C infection Jennifer M. RobertsJeffrey W. SearleW. G. E. Cooksley Serology and Epidemiology Pages: 37 - 41
Molecular classification of hepatitis C virus Masashi MizokamiKen-ichi Ohba Molecular Aspects Pages: 42 - 44
Effect of lymphoblastoid alfa-interferon in patients with chronic hepatitis C having different genotypic subtype of hepatitis C virus Kazuaki ChayamaAkihito TsubotaHiromitsu Kumada Molecular Aspects Pages: 45 - 47
Quantitative analysis of hepatitis C viras RNA: relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy Hideki HagiwaraNorio HayashiTakenobu Kamada Molecular Aspects Pages: 48 - 51
High detection rate of hepatitis C virus E2 antibody in patients with type C hepatitis Osamu YokosukaYoshimi ItoMasao Omata Molecular Aspects Pages: 52 - 54
Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence Keril BlightRichard LesniewskiEric Gowans Molecular Aspects Pages: 55 - 58
Interferon-γ, interleukin (IL)-2 and IL-2 receptor expressions in hepatitis C virus-infected liver Syed Ahmed MorshedHiroki FukumaMikio Nishioka Molecular Aspects Pages: 59 - 66
Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications Pei-Jer ChenLih-Hwa HwangDing-Shinn Chen Serum Markers and Clinical Aspects Pages: 67 - 70
Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C S. M. Fazle AkbarMorikazu OnjiYasuyuki Ohta Serum Markers and Clinical Aspects Pages: 71 - 75
Antibodies to hepatitis C virus and hepatitis C virus infection Nobukazu YukiNorio HayashiTakenobu Kamada Serum Markers and Clinical Aspects Pages: 76 - 79
Clinical evaluation of the antibody against core protein of hepatitis C virus Showgo OhkoshiMasashi WatanabeHitoshi Asakura Serum Markers and Clinical Aspects Pages: 80 - 83
Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis Susumu TakanoMasao OmataKozo Nakamura Serum Markers and Clinical Aspects Pages: 84 - 87
HCV infection in alcoholics B. NalpasV. ThiersC. Brechot Serum Markers and Clinical Aspects Pages: 88 - 90
Influence of HCV infection and its subtypes on clinical course of alcoholic liver disease S. NagataH. IshiiM. Tsuchiya Serum Markers and Clinical Aspects Pages: 91 - 94
Relevance of anti-HCV reactivity in patients with alcoholic hepatitis C. L. MendenhallT. MoritzVA Cooperative Study Group #275 Serum Markers and Clinical Aspects Pages: 95 - 100
Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial Rita LinChristopher LiddleFor the Australian Hepatitis C Study Group Therapy Pages: 101 - 103
Long-term therapeutic efficacy of interferon for patients with chronic hepatitis C Tadashi TakedaTetsuo KurokiKenzo Kobayashi Therapy Pages: 104 - 108
Autoimmunity during alpha-interferon therapy for chronic hepatitis C M. YoshikawaT. SakamotoT. Tsujii Therapy Pages: 109 - 114
Long-term effects of alpha-interferon for treatment of chronic hepatitis C in terms of histological changes with aminotransferase normalization and hepatitis C virus RNA seroconversion Kazuhiko HosodaOsamu YokosukaMasao Omata Therapy Pages: 115 - 117
Negative feedback regulation of acid secretion: Linkage of acid secretion and mucosal defense K. SuganoY. YoshidaS. Fukuchi Basic Approach Pages: 118 - 121
PGE2 protects isolated cells against injury through multiple mechanisms Choitsu SakamotoKohei MatsudaMasato Kasuga Basic Approach Pages: 122 - 126
Prospect of the treatment of human gastric ulcers with orally administered epidermal growth factor Makoto ItohShinpei ImaiToshihiko Takeuchi Basic Approach Pages: 127 - 131
Antioxidant protection against oxidant-induced damage in cultured gastric mucosal cells Hideyuki HiraishiNoriaki YajimaKevin J. Ivey Basic Approach Pages: 132 - 138
Alteration of gastric microcirculation in ulcer healing and recurrence: Significance of autonomic nervous regeneration and mesenchymal cell Masahiko NakamuraMasaki KitajimaMasaharu Tsuchiya Basic Approach Pages: 139 - 144
Quality of ulcer healing—A new concept to rank healed peptic ulcers Tetsuo ArakawaKenzo Kobayashi Clinical Approach Pages: 158 - 162
The role ofHelicobacter pylori in peptic ulcer disease Masahiro AsakaMototsugu KatoKazuaki Inoue Clinical Approach Pages: 163 - 167
Quality of healing in peptic ulcer disease—are H2 receptor antagonists all we need? Melvyn G. Korman Clinical Approach Pages: 168 - 171
Maintenance therapy for peptic ulcer—Who needs it? Denis M. McCarthy Clinical Approach Pages: 172 - 177
Endoscopic ultrasonographic (EUS) evaluation of the quality of gastric ulcer healing Ken KimuraYukio YoshidaKenichi Ido Clinical Approach Pages: 178 - 185
World Congresses of Gastroenterology October 2–7, 1994 Los Angeles, California Announcement Pages: 204 - 204
